Organigram said it has completed an early partial funding of its final third tranche investment into Phylos Bioscience Inc. (Phylos), a U.S. cannabis genetics company and provider of production-ready seeds, with the remaining portion of the final tranche to be funded upon completion of the newly expanded final milestone.
As part of the expanded milestone, Phylos is required to deliver 21 unique auto-flower seed varietals for testing and phenotyping by Organigram no later than September 30, 2024, followed by a second cohort of 21 auto flower seed varietals to be delivered no later than January 31, 2025. In addition to the auto-flower seeds, Organigram received an expanded genetics licence from Phylos that, in addition to THCV, includes access to high potency CBG, CBC and CBDV seed based cultivars.
Organigram has exclusive rights in Canada (until May 2028) to commercialize THCV derived from Phylos’ cultivars, including Get S**T Done (1:3 THC: THCV) and Joyride (1:1 THC:THCV), two popular cultivars with THCV concentrations of 16+% that are higher than those available elsewhere in the market.
Organigram was one of the first cannabis producers to launch THCV products in Canada with SHRED’ems late last year. Since then, Organigram has launched six THCV SKUs in-market, across four formats, in a variety of ratios for consumers to experience and enjoy. Organigram is currently the only cannabis producer in Canada to offer whole-flower derived THCV products in the pre-milled and pre-roll categories.
Organigram’s THCV portfolio includes:
- SHRED Supersonic Citrus THCV pre-milled Flower
- SHRED X Guava Lime Go-Time Heavies Infused Pre- rolls
- SHRED’ems Guava Lime Go-Time 1:1 THCV:THC Gummies
- SHRED’ems Pink Lemonade Yuzu 2:1 THCV:THC Gummies
- Trailblazer Hustle n’ Haze THCV pre-rolls
- Monjour Cherry Citrus Sunshine 8:3:1 CBD/THCV/THC Gummies
